共 159 条
[11]
Adelstein DJ(2006)Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck J Clin Oncol 24 2644-2652
[12]
Li Y(2003)A retrospective analysis of the outcome of patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R & M SCCHN) who are progressing while on a platinum-based palliative chemotherapy Proc Am Soc Clin Oncol 21 502-1715
[13]
Adams GL(2007)Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 1705-1704
[14]
Wagner H(2007)Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 1695-1044
[15]
Kish JA(2006)Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 65 1036-537
[16]
Ensley JF(1994)Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group Ann Oncol 5 533-1678
[17]
Forastiere AA(1996)Docetaxel: an active drug for squamous cell carcinoma of the head and neck J Clin Oncol 14 1672-462
[18]
Goepfert H(1999)A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck Br J Cancer 81 457-4756
[19]
Maor M(1995)An early phase II study of docetaxel (taxotere) in patients with head and neck cancer Proc Am Soc Clin Oncol 14 298-26
[20]
Pajak TF(1998)Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel Anticancer Res 18 4751-90